Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Peter Hölscher is active.

Publication


Featured researches published by Peter Hölscher.


Critical Care Medicine | 2009

Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury

Perenlei Enkhbaatar; Rhykka Connelly; Jianpu Wang; Yoshimitsu Nakano; Matthias Lange; Atsumori Hamahata; Eszter M. Horváth; Csaba Szabó; Stefan Jaroch; Peter Hölscher; Margrit Hillmann; Lillian D. Traber; Frank C. Schmalstieg; David N. Herndon; Daniel L. Traber

Objective:Acute respiratory distress syndrome/acute lung injury is a serious complication of burn patients with concomitant smoke inhalation injury. Nitric oxide has been shown to play a major role in pulmonary dysfunction from thermal damage. In this study, we have tested the hypothesis that inhibition of neuronal nitric oxide synthase could ameliorate the severity of acute lung injury using our well-established ovine model of cutaneous burn and smoke inhalation. Design:Prospective, randomized, controlled, experimental animals study. Setting:Investigational intensive care unit at university hospital. Subjects:Adult female sheep. Interventions:Female sheep (n = 16) were surgically prepared for the study. Seven days after surgery, all sheep were randomly allocated into three study groups: sham (noninjured, nontreated, n = 6); control (injured, treated with saline, n = 6); and neuronal nitric oxide synthase (injured, treated with specific neuronal nitric oxide synthase inhibitor, ZK 234238 (n = 4). Control and neuronal nitric oxide synthase groups were given a cutaneous burn (40% of total body surface, third degree) and insufflated with cotton smoke (48 breaths, <40°C) under halothane anesthesia. Animals in sham group received fake injury also under halothane anesthesia. After injury or fake injury procedure, all sheep were placed on ventilators and resuscitated with lactated Ringers solution. Neuronal nitric oxide synthase group was administered with continuous infusion of ZK 234238 started 1 hr postinjury with a dose of 100 &mgr;g/kg/hr. Sham and control groups received same amount of saline. Measurements and Main Results:Cardiopulmonary hemodynamics monitored during the 24-hr experimental time period was stable in the sham group. Control sheep developed multiple signs of acute lung injury. This pathophysiology included decreased pulmonary gas exchange and lung compliance, increased pulmonary edema, and inflammatory indices, such as interleukin-8. Treatment of injured sheep with neuronal nitric oxide synthase inhibitor attenuated all the observed pulmonary pathophysiology. Conclusions:The results provide definitive evidence that inhibition of neuronal nitric oxide synthase-derived excessive nitric oxide may be a novel and beneficial treatment strategy for pulmonary pathology in burn victims with smoke inhalation injury.


Archive | 1998

Substituted heterocycles and their use in medicaments

Peter Hölscher; Hartmut Rehwinkel; Detlev Suelzle; Gerardine Burton; Margrit Hillmann; Iris Pribilla; David Daniel Davey


Archive | 1998

Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals

Peter Hölscher; Hartmut Rehwinkel; Stefan Jaroch; Detlev Suelzle


Archive | 1999

3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors

Stefan Jaroch; Hartmut Rehwinkel; Peter Hölscher; Detlev Sülzle; Margrit Hillmann; Gerardine Burton; Fiona Mcdougall Mcdonald


Archive | 1999

Benzoxazine and benzothiazine derivatives and their use in medicines

Peter Hölscher; Hartmut Rehwinkel; Stefan Jaroch; Detlev Sülzle; Margrit Hillmann; Gerardine Burton; Fiona Mcdougall Mcdonald


Archive | 2004

DERIVADOS DE BENZOXAZINA Y BENZOTIAZINA Y SU UTILIZACION EN MEDICAMENTOS.

Gerardine Burton; Margrit Hillmann; Peter Hölscher; Stefan Jaroch; Fiona Mcdougall Mcdonald; Hartmut Rehwinkel; Detlev Sülzle


Archive | 2000

Derives de benzoxazine et de benzothiazine et leur utilisation dans des medicaments

Peter Hölscher; Hartmut Rehwinkel; Stefan Jaroch; Detlev Sülzle; Margrit Hillmann; Gerardine Burton; Fiona Mcdougall Mcdonald


Archive | 1999

Derivados de 3,4-dihidroxi-quinolina como agentes inhibidores de la monoxido de nitrogeno sintasa (nos).

Gerardine Burton; Margrit Hillmann; Peter Hölscher; Stefan Jaroch; Fiona Mcdougall Mcdonald; Hartmut Rehwinkel; Detlev Sülzle


Archive | 1999

Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors

Stefan Jaroch; Hartmut Rehwinkel; Peter Hölscher; Detlev Sülzle; Margrit Hillmann; Gerardine Burton; Fiona Macdougall Mcdonald


Archive | 1999

Derives de benzoxazine et de benzothiazine et leur utilisation dans des produits pharmaceutiques

Peter Hölscher; Hartmut Rehwinkel; Stefan Jaroch; Detlev Sülzle; Margrit Hillmann; Gerardine Burton; Fiona Mcdougall Mcdonald

Collaboration


Dive into the Peter Hölscher's collaboration.

Researchain Logo
Decentralizing Knowledge